Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model

Biological Chemistry

Volumn 389, Issue 6, 2008, Pages 719-723

  Koch, Matthias ^a   Bonaventura, Klaus ^a   Spillmann, Frank ^a   Dendorfer, Andreas ^b   Schultheiss, Heinz Peter ^a   Tschöpe, Carsten ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Bradykinin; Hemodynamics; Ischemia; Transgenic animal models

Indexed keywords

BRADYKININ; BUFFER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KININOGEN; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOVASCULAR RISK; CATHETER; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; EX VIVO STUDY; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RADIOIMMUNOASSAY; RAT; STATISTICAL SIGNIFICANCE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; KININOGENS; MALE; MUTATION; MYOCARDIAL INFARCTION; RAMIPRIL; RATS; VENTRICULAR DYSFUNCTION, LEFT;

ANIMALIA; RATTUS;

EID: 47549104476     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.083     Document Type: Conference Paper

References (30)

1. Agata, J., Chao, L., and Chao, J. (2002). Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension 40, 653-659.
2. Baumgarten, C.R., Linz, W., Kunkel, G., Schölkens, B.A., and Wiemer, G. (1993). Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br. J. Pharmacol. 108, 293-295.
3. Bischoff, A., Neumann, A., Dendorfer, A., and Michel, M.C. (1999). Is bradykinin a mediator of renal neuropeptide Y effects? Pflüger's Arch. 438, 797-803.
4. Biyashev, D., Tan, F., Chen, Z., Zhang, K., Deddish, P.A., Erdös, E.G., and Hecquet, C. (2006). Kallikrein activates bradykinin B2 receptors in absence of kininogen. Am. J. Physiol. Heart Circ. Physiol. 290, H1244-1250.
5. Bledsoe, G., Chao, L., and Chao, J. (2003). Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 285, H1479-H1488.
6. Emanueli, C., Salis, M.B., Pinna, A., Stacca, T., Milia, A.F., Spano, A., Chao, J., Chao, L., Sciola, L., and Maddedu, P. (2002). Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer. Circulation 106, 993-999.
7. Hashimoto, K., Hamamoto, H., Honda, Y., Hirose, M., Furukawa, S., and Kimura, E. (1978). Changes in components of kinin system and hemodynamics in acute myocardial infarction. Am. Heart J. 95, 619-626. I
8. gnjatovic, T., Tan, F., Brovkovych, V., Skidgel, R.A., and Erdös, E.G. (2002). Activation of bradykinin B1 receptor by ACE inhibitors. Int. Immunopharmacol. 2, 1787-1793.
9. Ignjatovic, T., Stanisavljevic, S., Brovkovych, V., Skidgel, R.A., and Erdös, E.G. (2004). Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signalling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands. Mol. Pharmacol. 66, 1310-1316.
10. Koch, M., Wendorf, M., Dendorfer, A., Wolfrum, S., Schulze, K., Spillmann, F., Schultheiss, H.-P., and Tschöpe, C. (2003). Cardiac kinin level in experimental diabetes mellitus: role of kininases. Am. J. Physiol. Heart Circ. Physiol. 285, H418-H423.
11. Koch, M., Spillmann, F., Dendorfer, A.,Westermann, D., Altmann, C., Sahabi, M., van Linthout, S., Bader, M., Walther, T., Schultheiss, H.P., and Tschöpe, C. (2006). Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction. Eur. J. Pharmacol. 21, 143-148.
12. Lamontagne, D., Nadeau, R., and Adam, A. (1995). Effect of enaprilat on bradykinin and des-Arg9-bradykinin release following reperfusion of the ischemic rat heart. Br. J. Pharmacol. 115, 476-478.
13. Liu, Y.H., Yang, X.-P., Mehta, D., Bulagannawar, M., Scicli, G.M., and Carretero, O.A. (2000). Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats. Am. J. Heart Circ. Physiol. 278, H507-514.
14. Liu, Y.-H., Yang, X.-P., Shesely, E.G., Steadman, S.S., and Carretero, O.A. (2004). Role of angiotensin II type 2 receptors and kinins in the cardioprotective effect of angiotensin II type 1 receptor antagonists in rats with heart failure. J. Am. Coll. Cardiol. 43, 1473-1480.
15. Marcic, B., Deddish, P.A., Skidgel, R.A., Erdös, E.G., Minshall, R.D., and Tan, F. (2000). Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors. J. Biol. Chem. 275, 16110-16118.
16. Nolly, H., Carbini, L.A., Scicli, G., Carretero, O.A., and Scicli, A.G. (1995). A local kallikrein-kinin system is present in hearts. Hypertension 23, 919-923.
17. Pinto, Y.M., Bader, M., Pesquero, J.B., Tschope, C., Scholtens, E., van Gilst, W.H., and Buikema, H. (2000). Increased kallikrein expression protects against cardiac ischemia. FASEB J. 14, 1861-1863.
18. Pitt, B., Mason, J., Conti, C.R., and Colman, R.W. (1970). Activation of plasma kallikrein system during myocardial ischemia. Adv. Exp. Med. Biol. 8, 343-347.
19. Silva, J.-A. Jr, Araujo, R.C., Baltatu, O., Oliveira, S.M., Tschope, C., Fink, E., Hoffmann, S., Plehm, R., Chai, K.X., Chao, L., et al. (2000). Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene. FASEB J. 14, 1858-1860.
20. Spillmann, F., Van Linthout, S., Schultheiss, H.-P., and Tschope, C. (2006). Cardioprotective mechanisms of the kallikrein-kinin system in diabetic cardiopathy. Curr. Opin. Nephrol. Hypertens. 15, 22-29.
21. Tonduangu, D., Hittinger, L., Ghaleh, B., Le Corvoisier, P., Sambin, L., Champagne, S., Badoual, T., Vencent, F., Berdeaux, A., Crozatier, B., and Su, J.B. (2004). Chronic infusion of bradykinin delays the progression of heart failure and preserves vascular endothelium-mediated vasodilatation in conscious dogs. Circulation 109, 114-119.
22. Tschõpe, C., Heringer-Walther, S., Koch, M., Spillmann, F., Wendorf, M., Hauke, D., Bader, M., Schultheiss, H.-P., andWalter, T. (2000). Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction. J. Hypertens. 18, 223-228.
23. Tschõpe, C., Schultheiss, H.-P., and Walther, T. (2002). Multiple interactions between the renin-angiotensin and the kallikreinkinin systems: role of ACE inhibition and AT1 receptor blockade. Cardiovasc. Pharmacol. 39, 478-487.
24. Tschõpe, C., Spillmann, F., Altmann, C., Koch, M., Westermann, D., Dhayat, N., Dhayat, S., Bascands, J.L., Gera, L., Hoffmann, S., et al. (2004a). The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction. Cardiovasc. Res. 61, 559-569.
25. Tschõpe, C., Walther, T., Kõniger, J., Spillmann, F., Westermann, D., Escher, F., Pauschinger, M., Pesquero, J.B., Bader, M., Schultheiss, H.-P., and Noutsias, M. (2004b). Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB J. 18, 828-835.
26. Westermann, D., Schultheiss, H.-P., and Tschõpe, C. (2008). New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration. Int. Immunopharmacol. 8, 148-154.
27. Wolf, W.C., Yoshida, H., Agata, J., Chao, L., and Chao, J. (2000). Human tissue kallikrein delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure. Kidney Int. 58, 730-739.
28. Xu, J., Carretero, O.A., Sun, Y., Shesely, E.G., Rhaleb, N.E., Liu, Y.-H., Liao, T.-D., Yang, J.J., Bader, M., and Yang, X.-P. (2005). Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction. Hypertension 45, 747-753.
29. Yang, X.-P., Liu, Y.-H., Scicli, G.M., Webb, C.R., and Carretero, O.A. (1997). Role of kinins in the cardioprotective effect of preconditioning. Study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogendeficient rats. Hypertension 30, 735-740.
30. Yoshida, H., Zhang, J., Chao, L., and Chao, J. (2000). Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension 35, 25-31.